pharmaceutical investing Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
pharmaceutical investing CytomX Therapeutics Announces Full-Year 2017 Financial Results and Provides Operational Update
pharmaceutical investing Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations
Steadright Critical Minerals Inc. to Acquire up to 75% Interest in the Péribonka Ree-Niobium Carbonatite Project, Saguenay-Lac-St-Jean Region, Québec
Prismo Metals Announces Listing of Blade Resources on the CSE Prismo Metals Owns 6,755,000 Shares of Blade Resources
Goldgroup Highlights Its Two Producing Mines and Significant Growth Potential Across the Don David Gold Complex in Mexico
